Coronary heart disease and stroke deaths - United States, 2009

MMWR Supplements
|November 23, 2013
PubMed

Insights

Heart disease and stroke cause over 30% of US deaths, with coronary heart disease (CHD) being the leading cause. Despite declining rates, significant reductions are still needed, especially for men and Black individuals.

Area of Science:

  • Public Health
  • Cardiovascular Disease Epidemiology

Background:

  • Heart disease and stroke are leading causes of death in the US, accounting for nearly a third of all deaths in 2008.
  • Coronary heart disease (CHD) is the primary cause of heart disease-related mortality.
  • Despite declining trends, death rates from CHD and stroke remain high, particularly in specific demographics.

Purpose of the Study:

  • To highlight the significant public health burden of heart disease and stroke in the United States.
  • To outline the Healthy People 2020 objectives for reducing CHD and stroke mortality rates.
  • To emphasize the persistent disparities in cardiovascular disease death rates among men and Black populations.

Main Methods:

  • Analysis of mortality data for heart disease and stroke in the United States.
  • Review of Healthy People 2020 objectives for CHD and stroke death rate reduction.
  • Comparison of current death rates with established public health goals.

Main Results:

  • In 2008, heart disease and stroke combined caused over 750,000 deaths, representing 30.4% of all US deaths.
  • Coronary heart disease (CHD) accounted for over two-thirds of heart disease deaths.
  • Healthy People 2020 aims to reduce CHD deaths to 100.8 per 100,000 and stroke deaths to 33.8 per 100,000 population.

Conclusions:

  • Heart disease and stroke remain critical public health challenges in the US.
  • Achieving the Healthy People 2020 targets requires continued efforts to reduce mortality.
  • Addressing health disparities is crucial, as men and Black individuals experience disproportionately high death rates.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
510
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
541
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
728